| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.0025 | 1 |